Physician profile
Khalil El-Chammas
NPI 1285800276
$14,858.06
in general payments reported to CMS, 2019-2025
8 companies · $2,291 in 2025
The $2,291 reported for 2025 was more than what 87% of Pediatric Gastroenterology providers received nationally (typical 2025 total: $195).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,070 · 2020: $1,000 · 2021: $5,308 · 2022: $767 · 2023: $2,025 · 2024: $2,397 · 2025: $2,291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,750 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000 · Food and Beverage: $963.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,750.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
| Food and Beverage | $963.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laborie Medical Technologies Corp. | $12,027.77 | 2019-2025 | Solar Compact |
| Neuraxis, INC. | $2,202.74 | 2020-2024 | |
| Regeneron Pharmaceuticals, INC. | $129.68 | 2025 | Dupixent |
| Abbvie INC. | $126.06 | 2024 | |
| Covidien LP | $118.84 | 2019 | |
| Coloplast Corp | $112.66 | 2025 | |
| Boston Scientific Corporation | $107.88 | 2021 | |
| Dentsply Ih Ab | $32.43 | 2025 | Navina Rectal Catheter Set Regular |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khalil El-Chammas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.